Crescom gained U.S. FDA 510(k) clearance for MediAI‑BA, an AI‑powered pediatric and adolescent bone age analysis software that estimates adult height from hand and wrist X‑rays. The clearance designates MediAI‑BA as a class II medical device. Clinical trial data showed specialist‑level accuracy with a mean absolute deviation of 0.39 years. The software offers automated bone‑age assessment and predicted adult height suggestions to support radiologists and pediatric endocrinologists. The clearance expands AI imaging tools available in pediatrics and may accelerate adoption of algorithmic decision support in growth and endocrine clinics.